跳至主要内容
临床试验/NCT02685215
NCT02685215Unknown不适用

Prognostic Factors, Morbidity, Mortality and Long Term Survival in Patients With Neuromuscular Disorders Admitted in Intensive Care Unit

Centre d'Investigation Clinique et Technologique 8051 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2016年3月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
800
试验地点
1
主要终点
ICU mortality

研究概览

简要总结

Muscular dystrophies are neuromuscular disorders with disability. Restrictive pulmonary failure and cardiomyopathy affect prognosis.The investigators aim to establish predictive factors for mortality and morbidity in Intensive care unit (ICU ) and to describe the long term follow up after ICU discharge.

详细描述

Muscular dystrophies are neuromuscular disorders with disability. Restrictive pulmonary failure and cardiomyopathy affect prognosis. Little is known about morbidity and mortality of patients with muscular dystrophies admitted in intensive care unit (ICU).The investigators aim to describe the spectrum of patients with muscular dystrophies admitted in ICU , to establish predictive factors for ICU mortality and morbidity and to describe the long term follow up after ICU discharge.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • admitted in ICU
  • Duchenne muscular dystrophy
  • Becker muscular dystrophy
  • Steinert disease
  • Pompe disease
  • metabolic disease
  • mitochondrial disease
  • congenital myopathy
  • others neuro-muscular diseases

排除标准

  • brain injury
  • minor patient

结局指标

主要结局

ICU mortality

时间窗: 1 month

次要结局

  • tracheostomy in ICU(1 month)
  • decline of vital capacity after ICU stay(2 years)
  • long term survival after ICU stay(5 years)
  • predictive factors for re admission in ICU(1 year)

研究者

发起方
Centre d'Investigation Clinique et Technologique 805
申办方类型
Other
责任方
Principal Investigator
主要研究者

Abdallah FAYSSOIL

MD PhD

Centre d'Investigation Clinique et Technologique 805

研究点 (1)

Loading locations...

相似试验

Prognostic Factors , Morbidity and Mortality in... | 临床试验